{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,4,26]],"date-time":"2025-04-26T05:26:09Z","timestamp":1745645169701},"reference-count":11,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2010,10,22]],"date-time":"2010-10-22T00:00:00Z","timestamp":1287705600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Int J Hematol"],"published-print":{"date-parts":[[2010,11]]},"DOI":"10.1007\/s12185-010-0706-6","type":"journal-article","created":{"date-parts":[[2010,10,21]],"date-time":"2010-10-21T01:27:07Z","timestamp":1287624427000},"page":"664-666","source":"Crossref","is-referenced-by-count":7,"title":["Expanded distribution of the T315I mutation among hematopoietic stem cells and progenitors in a chronic myeloid leukemia patient during imatinib treatment"],"prefix":"10.1007","volume":"92","author":[{"given":"Yosuke","family":"Minami","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tomohiro","family":"Kajiguchi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Akihiro","family":"Abe","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Toshihito","family":"Ohno","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hitoshi","family":"Kiyoi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tomoki","family":"Naoe","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2010,10,22]]},"reference":[{"key":"706_CR1","doi-asserted-by":"crossref","first-page":"5271","DOI":"10.1182\/blood-2009-04-219410","volume":"114","author":"FE Nicolini","year":"2009","unstructured":"Nicolini FE, Mauro MJ, Martinelli G, Kim DW, Soverini S, Muller MC, et al. Epidemiologic study on survival of chronic myeloid leukemia and Ph+ acute lymphoblastic leukemia patients with BCR-ABL T315I mutation. Blood. 2009;114:5271\u20138.","journal-title":"Blood"},{"key":"706_CR2","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1038\/nrclinonc.2009.112","volume":"6","author":"A Quintas-Cardama","year":"2009","unstructured":"Quintas-Cardama A, Kantarjian H, Cortes J. Imatinib and beyond-exploring the full potential of targeted therapy for CML. Nat Rev Clin Oncol. 2009;6:535\u201343.","journal-title":"Nat Rev Clin Oncol"},{"key":"706_CR3","doi-asserted-by":"crossref","first-page":"5426","DOI":"10.1182\/blood-2009-08-215939","volume":"114","author":"S Branford","year":"2009","unstructured":"Branford S, Melo JV, Hughes TP. Selecting optimal second-line tyrosine kinase inhibitor therapy for chronic myeloid leukemia patients after imatinib failure: does the BCR-ABL mutation status really matter? Blood. 2009;114:5426\u201335.","journal-title":"Blood"},{"key":"706_CR4","doi-asserted-by":"crossref","first-page":"657","DOI":"10.1056\/NEJMoa040258","volume":"351","author":"CH Jamieson","year":"2004","unstructured":"Jamieson CH, Ailles LE, Dylla SJ, Muijtjens M, Jones C, Zehnder JL, et al. Granulocyte-macrophage progenitors as candidate leukemic stem cells in blast-crisis CML. N Engl J Med. 2004;351:657\u201367.","journal-title":"N Engl J Med"},{"key":"706_CR5","doi-asserted-by":"crossref","first-page":"471","DOI":"10.1007\/s12185-008-0221-1","volume":"88","author":"A Abe","year":"2008","unstructured":"Abe A, Minami Y, Hayakawa F, Kitamura K, Nomura Y, Murata M, et al. Retention but significant reduction of BCR-ABL transcript in hematopoietic stem cells in chronic myelogenous leukemia after imatinib therapy. Int J Hematol. 2008;88:471\u20135.","journal-title":"Int J Hematol"},{"key":"706_CR6","doi-asserted-by":"crossref","first-page":"6041","DOI":"10.1200\/JCO.2009.25.0779","volume":"27","author":"M Baccarani","year":"2009","unstructured":"Baccarani M, Cortes J, Pane F, Niederwieser D, Saglio G, Apperley J, et al. Chronic myeloid leukemia: an update of concepts and management recommendations of European LeukemiaNet. J Clin Oncol. 2009;27:6041\u201351.","journal-title":"J Clin Oncol"},{"key":"706_CR7","doi-asserted-by":"crossref","first-page":"680","DOI":"10.1093\/jnci\/djk150","volume":"99","author":"X Jiang","year":"2007","unstructured":"Jiang X, Saw KM, Eaves A, Eaves C. Instability of BCR-ABL gene in primary and cultured chronic myeloid leukemia stem cells. J Natl Cancer Inst. 2007;99:680\u201393.","journal-title":"J Natl Cancer Inst"},{"key":"706_CR8","doi-asserted-by":"crossref","first-page":"2265","DOI":"10.1056\/NEJMc035089","volume":"348","author":"C Roche-Lestienne","year":"2003","unstructured":"Roche-Lestienne C, La\u00ef JL, Darr\u00e9 S, Facon T, Preudhomme C. A mutation conferring resistance to imatinib at the time of diagnosis of chronic myelogenous leukemia. N Engl J Med. 2003;348:2265\u20136.","journal-title":"N Engl J Med"},{"key":"706_CR9","doi-asserted-by":"crossref","first-page":"1761","DOI":"10.4161\/cc.4.12.2261","volume":"4","author":"T Lange","year":"2005","unstructured":"Lange T, Park B, Willis SG, Deininger MW. BCR-ABL kinase mutations in chronic myeloid leukemia: not quite enough to cause resistance to imatinib therapy? Cell Cycle. 2005;4:1761\u20136.","journal-title":"Cell Cycle"},{"key":"706_CR10","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1038\/sj.leu.2404554","volume":"21","author":"DW Sherbenou","year":"2007","unstructured":"Sherbenou DW, Wong MJ, Humayun A, McGreevey LS, Harrell P, Yang R, et al. Mutations of the BCR-ABL-kinase domain occur in a minority of patients with stable complete cytogenetic response to imatinib. Leukemia. 2007;21:489\u201393.","journal-title":"Leukemia"},{"key":"706_CR11","doi-asserted-by":"crossref","first-page":"2854","DOI":"10.1200\/JCO.2007.15.2421","volume":"26","author":"F Michor","year":"2008","unstructured":"Michor F. Mathematical models of cancer stem cells. J Clin Oncol. 2008;26:2854\u201361.","journal-title":"J Clin Oncol"}],"container-title":["International Journal of Hematology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12185-010-0706-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s12185-010-0706-6\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12185-010-0706-6","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,6,2]],"date-time":"2019-06-02T05:01:36Z","timestamp":1559451696000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s12185-010-0706-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,10,22]]},"references-count":11,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2010,11]]}},"alternative-id":["706"],"URL":"https:\/\/doi.org\/10.1007\/s12185-010-0706-6","relation":{},"ISSN":["0925-5710","1865-3774"],"issn-type":[{"value":"0925-5710","type":"print"},{"value":"1865-3774","type":"electronic"}],"subject":[],"published":{"date-parts":[[2010,10,22]]}}}